The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Contemporary treatment patterns and short-term outcomes in men with very high-risk prostate cancer.
 
Jeffrey J. Tosoian
No Relationships to Disclose
 
Debasish Sundi
No Relationships to Disclose
 
Brian Francis Chapin
No Relationships to Disclose
 
Emmanuel S. Antonarakis
Honoraria - Dendreon; Janssen Biotech; Medivation; Sanofi
Consulting or Advisory Role - Dendreon; Janssen Biotech; Medivation; Sanofi
Research Funding - Aragon Pharmaceuticals (Inst); Dendreon (Inst); Exelixis (Inst); Genentech (Inst); Janssen Biotech (Inst); Johnson & Johnson (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Dendreon; Medivation; Sanofi
 
Meera Chappidi
No Relationships to Disclose
 
Ridwan Alam
No Relationships to Disclose
 
Stephanie Glavaris
No Relationships to Disclose
 
R. Jeffrey Karnes
No Relationships to Disclose
 
Kenneth J. Pienta
Leadership - Curis
Honoraria - Johnson & Johnson
Research Funding - Johnson & Johnson (Inst)
 
Phuoc T. Tran
Consulting or Advisory Role - Astellas Pharma; GenomeDx; Regeneron
Research Funding - Astellas Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Compounds and Methods of Use in Ablative Radiotherapy. Patent filed 3/9/2012. PCT/US2012/028475. PCT/WO/2012/122471.
 
Edward M. Schaeffer
Consulting or Advisory Role - GenomeDx
 
Ashley Ross
No Relationships to Disclose